Clearance Summary
Biopsy Forceps received FDA 510(k) clearance under submission number K252722, sponsored by Fehling Instruments GmbH. The device was reviewed via the Special premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2025-09-30.
- Submission: K252722
- Applicant / Sponsor: Fehling Instruments GmbH
- Clearance pathway: Special
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.4075
- Decision date: 2025-09-30
Classification & Regulation
This clearance is catalogued under FDA product code DWZ and 21 CFR 870.4075, within the Cardiovascular review panel as a Class II device.